Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of $0.36, $0.81 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $20.29 million.

GUIDANCE:

Pulmonx Corporation sees FY2024 revenue of $81-84 million, versus the consensus of $82.634 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.